caus
major
childhood
vasculitid
unknown
although
like
complex
interact
environment
factor
inherit
host
respons
trigger
diseas
determin
vascul
phenotyp
epidemiolog
clue
continu
implic
infecti
trigger
kawasaki
syndrom
ks
henoch
purpura
hsp
sever
genet
polymorph
describ
ks
hsp
predispos
diseas
predict
diseas
sever
antineutrophil
cytoplasm
antibodi
anca
known
directli
involv
pathogenesi
vascular
injuri
ancaassoci
vasculitid
although
individu
develop
anca
first
instanc
yet
understood
endotheli
injuri
repair
activ
area
research
vascul
possibl
track
endotheli
injuri
noninvas
children
vascul
use
surrog
marker
endotheli
injuri
vasculogen
pathway
involv
vascular
repair
follow
vascul
includ
endotheli
progenitor
cell
begin
studi
anticip
improv
understand
aetiopathogenesi
vascul
young
ultim
shape
futur
novel
diagnost
therapeut
approach
help
us
predict
children
may
develop
prematur
arteriosclerosi
later
life
primari
system
vascul
psv
rare
children
still
associ
signific
mortal
morbid
primari
vasculit
syndrom
includ
amongst
other
henoch
purpura
hsp
kawasaki
syndrom
ks
polyarter
nodosa
pan
takayasu
diseas
td
antineutrophil
cytoplasm
antibodi
anca
associ
vasculitid
aav
compris
wegen
granulomatosi
wg
microscop
polyangi
renal
limit
vascul
churgstrauss
syndrom
psv
characteris
presenc
inflamm
wall
blood
vessel
result
tissu
ischaemia
necrosi
caus
major
childhood
vasculitid
unknown
although
like
complex
interact
environment
factor
infect
inherit
host
respons
trigger
diseas
determin
vascul
phenotyp
review
summaris
find
recent
studi
relat
aetiopathogenesi
psv
consid
two
broad
head
environment
trigger
host
respons
articl
focu
therapi
psv
articl
describ
comprehens
possibl
infect
organ
known
associ
secondari
infect
vascul
recent
review
pagnoux
et
al
naid
psv
young
yet
fail
definit
cast
light
aetiolog
psv
children
epidemiolog
data
readili
avail
two
commonest
form
psv
children
hsp
ks
rel
data
relat
epidemiolog
pan
aav
children
common
theme
emerg
relat
season
ethnic
predisposit
particular
relat
ks
hint
infecti
precipit
andor
genet
determin
hostrespons
ks
commonest
japan
japanes
orient
children
live
abroad
children
age
month
year
suscept
peak
incid
children
age
month
season
variat
ks
incid
report
peak
occurr
winter
spring
month
outbreak
ks
link
weather
pattern
cluster
ks
case
occur
associ
precipit
direct
persontoperson
spread
observ
although
japan
diseas
occur
commonli
sibl
index
case
estim
peak
incid
sibl
age
year
current
estim
incid
ks
uk
per
children
age
yearsan
incid
doubl
sinc
increas
may
truli
indic
increas
incid
better
case
recognit
may
partli
account
rise
trend
whilst
observ
suggest
infecti
aetiolog
hunt
singl
infecti
agent
far
prove
fruit
fact
recent
highlight
neg
result
emerg
studi
examin
potenti
link
coronaviru
infect
ks
taiwan
like
ks
repres
extrem
endpoint
number
potenti
infecti
agent
genet
predispos
individu
prompt
recent
chang
nomenclatur
kawasaki
diseas
kawasaki
syndrom
serv
focu
attent
host
respons
rather
specif
infecti
agent
hsp
similar
ks
also
appear
season
variat
occur
commonli
autumn
winter
yang
et
al
comment
cluster
hsp
autumn
winter
often
preced
upper
respiratori
infect
point
possibl
hsp
infectionrel
possibl
incit
agent
streptococci
bartonella
hensela
parvoviru
hiv
varicella
amongst
other
ks
howev
singl
infecti
agent
identifi
like
genet
control
host
respons
determin
whether
individu
develop
hsp
respons
infecti
trigger
epidemiolog
studi
aav
adult
provid
import
clue
relat
environment
genet
factor
see
may
involv
aetiopathogenesi
syndrom
geograph
distribut
aav
diseas
occurr
adult
suggest
wg
occur
commonli
northern
european
countri
southern
european
countri
twofold
higher
annual
incid
observ
norway
england
lugo
spain
human
leukocyt
antigen
hla
makeup
lugo
popul
differ
found
mediterranean
area
similar
proport
allel
found
uk
popul
sinc
clear
hla
associ
shown
type
psv
behcet
diseas
watt
et
al
suggest
environment
factor
may
import
genet
factor
wg
context
pictur
emerg
potenti
relationship
occup
crystallin
silica
exposur
aav
observ
number
studi
overal
exposur
siliconcontain
compound
found
relat
aav
particularli
wg
odd
ratio
mechan
silica
may
induc
aav
well
known
siliconcontain
compound
may
immun
adjuv
sinc
silica
particl
potent
stimul
lymphocyt
monocyt
macrophag
silica
particl
may
also
stimul
neutrophilreact
oxygen
radic
releas
inflammatori
cytokin
trigger
exocytosi
proteinas
myeloperoxidas
antigen
surfac
polynuclear
neutrophil
thu
prime
neutrophil
anca
activ
see
whether
risk
factor
import
wg
children
young
adult
howev
question
miscellan
environment
risk
factor
aav
adult
report
smoke
found
research
either
protect
effect
effect
put
trigger
wg
drug
exposur
notabl
propylthiouracil
hydralazin
link
malign
onset
wg
factor
howev
like
less
relev
risk
factor
paediatr
aav
mani
pathogen
known
either
directli
caus
vascul
act
potenti
trigger
psv
mani
virus
bacteria
fungi
directli
caus
vascul
demonstr
tissu
tropism
includ
endothelium
agent
may
bind
vessel
wall
vascular
endothelium
express
specif
receptor
pathogen
even
agent
enter
endotheli
cell
immun
respons
agent
may
still
focus
endothelium
pathogen
adher
endotheli
cell
surfac
result
bystand
injuri
endothelium
vessel
superantigen
psv
superantigen
sag
one
environment
factor
propos
modul
number
autoimmun
diseas
includ
vascul
compel
evid
involv
sag
pathogenesi
vascul
relat
ks
although
hypothesi
prove
controversi
sag
class
immunostimulatori
protein
bacteri
viral
origin
abil
activ
larg
fraction
cell
popul
respons
human
toxic
shock
syndrom
form
gastroenter
class
ii
major
histocompat
complex
mhc
posit
endotheli
cell
oper
compet
sagpres
cell
lymphocyt
vitro
dual
signal
endotheli
cell
cell
result
activ
adher
endothelium
result
endotheli
cell
activ
injuri
thu
sag
could
mechanist
result
sever
endotheli
vascular
injuri
could
account
part
vascular
injuri
associ
sagmedi
diseas
toxic
shock
syndrom
one
import
controversi
issu
ongo
debat
regard
sag
versu
convent
antigen
aetiopathogenesi
ks
similar
clinic
immunolog
featur
ks
sag
toxinmedi
staphylococc
streptococc
toxic
shock
syndrom
scarlet
fever
studi
abe
et
al
first
describ
select
expans
cell
ks
indic
cell
skewingth
hallmark
sagmedi
process
sinc
mani
similar
studi
examin
cell
repertoir
ks
examin
preval
serolog
convers
colonis
sagproduc
organ
anoth
import
observ
cell
infiltr
wall
coronari
arteri
aneurysm
intestin
mucosa
patient
ks
show
skew
cell
repertoir
increas
number
cell
express
possibl
indic
sagdriven
process
howev
rowley
et
al
recent
report
three
fatal
case
kd
observ
iga
plasma
cell
infiltr
vascular
wall
acut
phase
ill
examin
clonal
iga
respons
use
revers
transcriptas
rt
pcr
lesion
vascular
tissu
research
observ
iga
respons
oligoclon
suggest
convent
ag
process
rather
sagdriven
one
synthet
version
preval
iga
antibodi
use
immunohistochem
experi
acut
ks
control
tissu
sever
preval
iga
antibodi
detect
antigen
lesion
ks
tissu
control
tissu
studi
indic
antigen
resid
cytoplasm
inclus
bodi
possibl
consist
aggreg
viral
protein
nucleic
acid
import
observ
may
suggest
common
infecti
aetiolog
ks
perhap
viral
may
cast
doubt
sag
hypothesi
ks
recent
describ
cell
repertoir
number
paediatr
vasculit
syndrom
like
other
found
evid
expans
peripher
blood
ks
patient
skew
peripher
blood
cell
repertoir
children
psv
predominantli
pan
skew
repertoir
observ
hsp
patient
data
provid
impetu
research
contenti
field
resolv
unequivoc
question
role
sag
childhood
vasculit
syndrom
said
recent
multicent
review
turkish
children
pan
implic
streptococc
infect
aetiopathogenesi
vasculit
syndrom
whether
mechan
molecular
mimicri
convent
antigen
superantigenicmedi
vascular
injuri
unknown
thu
juri
remain
sag
hypothesi
psv
young
sever
group
activ
research
relationship
staphylococcu
aureu
wg
increas
incid
chronic
nasal
carriag
aureu
patient
wg
associ
increas
risk
diseas
relaps
moreov
relaps
wg
reduc
use
longterm
trimethoprimsulphamethoxazol
although
current
unclear
whether
efficaci
result
erad
nasal
carriag
aureu
virtu
potenti
antiinflammatori
effect
trimethoprimsulphamethoxazol
exert
antibiot
effect
antagonis
folic
acid
metabol
mechan
could
affect
leucocyt
possibl
mechan
wherebi
aureu
could
result
flare
wg
includ
sag
product
b
cell
activ
direct
tropism
aureu
endotheli
cell
bind
internalis
organ
endotheli
cell
prime
neutrophil
see
note
howev
observ
carriag
staphylococc
strain
posit
sag
gene
wg
patient
associ
expect
pattern
sagreact
cell
propos
mechan
data
current
suggest
effect
aureu
endotheli
cell
andor
phagocyt
cell
may
plausibl
rel
scant
evid
sag
effect
base
studi
pattern
cell
skew
genet
predisposit
vasculitid
sever
investig
examin
potenti
genet
factor
predispos
vascul
famili
case
vascul
includ
pan
ks
aav
td
describ
clear
studi
howev
predispos
genet
factor
psv
complex
multipl
vari
differ
vasculit
syndrom
previous
genet
studi
focus
aav
although
number
public
recent
appear
report
import
mutat
andor
polymorph
ks
hsp
biezeveld
et
al
recent
report
associ
mannosebind
lectin
mbl
genotyp
cardiovascular
abnorm
ks
mbl
macromolecul
collagen
sugarbind
domain
abl
activ
complement
pathway
directli
ie
independ
antibodi
mbl
thu
third
limb
complement
cascad
term
mbl
pathway
particular
mbl
bind
repeat
nacetylglucosamin
mannos
residu
express
surfac
mani
microbi
antigen
defici
mbl
found
third
healthi
popul
associ
increas
risk
bacteri
viral
infect
children
thu
mbl
import
compon
innat
immun
system
particularli
acut
phase
infect
infant
period
decreas
level
matern
antibodi
develop
adapt
immun
especi
depend
molecul
two
studi
caucasian
children
ks
netherland
biezeveld
et
al
observ
appear
ambigu
role
mbl
context
infant
ks
year
age
higher
risk
develop
coronari
arteri
aneurysm
caa
polymorph
gene
correl
low
plasma
mbl
level
present
odd
ratio
confid
interv
age
year
revers
true
wildtyp
mbl
genotyp
normal
plasma
mbl
level
associ
greater
risk
caa
thu
appear
mbl
modul
host
respons
cardiovascular
injuri
differ
depend
age
infant
age
year
normal
mbl
level
may
protect
put
infect
organ
trigger
vascular
injuri
ks
wherea
older
children
critic
depend
mbl
innat
immun
mbl
acut
phase
protein
could
contribut
endotheli
injuri
uncontrol
complement
activ
date
limit
data
examin
role
mbl
genotyp
vasculitid
endo
et
al
detect
glomerular
deposit
mbl
mblassoci
serin
proteas
well
protein
eight
ten
patient
hsp
nephriti
suggest
role
mbl
glomerular
injuri
associ
hsp
mutat
polymorph
sever
miscellan
gene
recent
describ
ks
either
diseasesuscept
gene
influenc
risk
caa
develop
respons
treatment
summaris
tabl
sever
polymorph
relat
diseas
suscept
sever
andor
risk
renal
involv
recent
describ
mani
polymorph
relat
cytokin
cell
adhes
molecul
involv
modul
inflammatori
respons
endotheli
cell
activ
may
therefor
relev
autoimmun
diseas
well
hsp
whole
studi
natur
hamper
rel
small
patient
number
thu
lack
power
definit
necessarili
applic
racial
group
studi
summaris
tabl
plethora
studi
examin
multipl
put
gene
may
involv
aetiopathogenesi
aav
summaris
tabl
recent
evid
anca
directli
involv
pathogenesi
vascular
injuri
document
compel
evid
report
two
neonat
develop
pulmonari
renal
syndrom
soon
birth
transplacent
transfer
igg
mpoanca
mother
activ
microscop
polyangi
mpa
moreov
mous
model
recent
describ
xiao
et
al
show
passiv
transfer
mpoanca
antimpo
lymphocyt
make
mpoanca
mice
lack
function
b
cell
rag
result
pauciimmun
crescent
nephriti
small
vessel
vascul
similar
observ
human
aav
thu
evid
mpoanca
directli
involv
pathogenesi
vascular
injuri
grow
may
still
somewhat
debat
plethora
public
describ
detail
mechan
vascular
injuri
mediat
anca
ace
id
polymorph
increas
diseas
suscept
associ
hsp
nephriti
polymorph
ace
albeit
studi
involv
small
number
children
studi
polymorph
result
higher
frequenc
caa
genet
studi
may
elev
hsp
genet
studi
mmp
express
lesion
glomerular
tissu
vascular
endotheli
growth
factor
vegf
receptor
kdr
polymorph
contribut
increas
caa
risk
vegf
polymorph
predispos
renal
involv
genet
studi
vegf
elev
activ
wg
interleukin
receptor
antagonist
polymorph
associ
increas
diseas
suscept
polymorph
predispos
renal
involv
studi
interleukin
associ
found
polymorph
associ
renal
involv
one
studi
fail
identifi
associ
polymorph
wg
tumour
necrosi
factoralpha
associ
increas
intraven
immun
globulin
ivig
resist
tnfalpha
polymorph
associ
hsp
chines
patient
one
studi
fail
identifi
associ
polymorph
wg
polymorph
associ
renal
involv
genet
studi
gene
promot
polymorph
influenc
risk
caa
genet
studi
polymorph
associ
wg
mpa
chemokin
chemokin
receptor
ligand
influenc
diseas
suscept
genet
studi
genet
studi
famili
mediterranean
fever
genotyp
mefv
gene
mutat
genet
studi
mutat
mefv
found
commonli
isra
turkish
children
hsp
genet
studi
human
leucocyt
antigen
hla
consist
associ
posit
predispos
renal
involv
hsp
consist
associ
pair
box
gene
genet
studi
polymorph
predispos
renal
involv
hsp
genet
studi
nitric
oxid
associ
molecul
associ
ecno
ino
gene
polymorph
develop
cal
japanes
ks
patient
induc
nitric
oxid
synthas
promot
polymorph
predispos
renal
involv
genet
studi
genet
yet
studi
patient
carri
codon
ke
genotyp
decreas
risk
develop
sever
gastrointestin
complic
polymorph
exon
gene
associ
mpoanca
vascul
relev
polymorph
identifi
eselectin
human
urokinas
plasminogen
activ
receptor
gene
eloqu
summaris
recent
review
accept
model
pathogenesi
propos
anca
activ
cytokineprim
neutrophil
lead
bystand
damag
endotheli
cell
escal
inflamm
recruit
mononuclear
cell
neutrophil
prime
involv
stimul
agent
lipopolysaccharid
lp
cytokin
tumour
necrosi
factor
alpha
concentr
caus
full
function
activ
rather
result
transloc
ancaantigen
mpo
andor
intracellular
granul
cell
surfac
prime
subsequ
anca
activ
neutrophil
lead
respiratori
burst
degranul
therebi
gener
potenti
endotheli
injuri
bind
anca
antigen
express
surfac
prime
neutrophil
enough
caus
full
neutrophil
activ
bind
fc
receptor
also
necessari
follow
neutrophil
stimul
anca
numer
cytotox
mediat
releas
includ
reactiv
oxygen
speci
chemokin
cytokin
proteolyt
enzym
nitric
oxid
firm
adhes
activ
neutrophil
endotheli
cell
result
endotheli
cell
damag
perhap
recruit
inflammatori
cell
includ
monocyt
cell
follow
neutrophil
activ
anca
neutrophil
driven
acceler
aberr
apoptot
pathway
thu
neutrophil
develop
morpholog
featur
apoptosi
failur
cell
surfac
chang
bilipid
cellular
membran
phosphatidylserin
ps
externalis
normal
earli
featur
apoptot
cell
lack
ps
externalis
mean
phagocyt
less
abl
process
apoptot
neutrophil
nonphlogist
fashion
explain
wellcharacteris
find
leucocytoclasi
often
seen
vasculit
lesion
certain
vasculit
syndrom
aforement
clinic
experiment
evid
support
role
anca
pathogenesi
aav
explain
anca
develop
certain
individu
one
emerg
hypothesi
could
cast
light
area
term
complementar
theori
central
premis
theori
autoantibodi
gener
immun
respons
initi
mount
peptid
antisens
complementari
autoantigen
implic
infecti
agent
could
trigger
anca
gener
via
microbi
peptid
act
molecular
mimic
complementari
inde
aureu
contain
peptid
sequenc
mimic
antisens
ross
river
viru
entamoeba
histolytica
infect
previous
associ
anca
gener
genet
studi
isol
case
report
sever
multisystem
hsp
defici
associ
defici
pizz
phenotyp
describ
defici
suffici
caus
ancaposit
vasculitid
may
act
amplifi
factor
genet
studi
genet
studi
associ
polymorph
promot
wg
associ
vf
genet
studi
possibl
associ
allel
patient
wg
renal
involv
may
predispos
diseas
relaps
cytotox
lymphocyteassoci
genet
studi
polymorph
associ
wg
ks
kawasaki
syndrom
hsp
henoch
purpura
aav
antineutrophil
cytoplasm
antibodi
anca
associ
vasculitid
polymorph
human
theori
autoantigen
complementar
could
thu
import
implic
pathogenesi
autoimmun
diseas
need
valid
number
studi
look
biomark
predict
caa
ks
two
biomark
deserv
particular
mention
context
matrix
metalloproteinas
mmp
protein
imbal
mmp
tissu
inhibitor
mmp
timp
implic
develop
caa
ks
extracellular
matrix
maintain
rigor
control
balanc
synthesi
breakdown
compon
protein
mmp
timp
play
central
role
process
children
ks
high
level
mmp
andor
high
mmptimp
ratio
suscept
coronari
arteri
lesion
calciumbind
protein
famili
potenti
biomark
ks
caa
protein
form
heterodim
secret
neutrophil
monocyt
respons
inflammatori
signal
cascad
heterodim
bind
microvascular
endotheli
cell
may
particip
genesi
proinflammatori
prothrombot
state
system
vascul
specif
protein
regul
adhes
neutrophil
monocyt
endotheli
cell
implic
transmigr
vessel
wall
serum
level
well
mrna
express
granulocyt
upregul
acut
ks
decreas
dramat
within
h
intraven
immun
globulin
ivig
therapi
number
circul
endotheli
cell
cec
see
higher
patient
acut
kd
control
patient
number
increas
significantli
week
onset
kd
especi
patient
coronari
arteri
lesion
develop
one
import
implic
observ
pathway
could
provid
new
therapeut
target
ivig
nonrespond
sever
caa
partial
ivig
respons
much
interest
role
downstream
mediat
endotheli
vascular
injuri
potenti
therapeut
blockad
cytokin
number
paediatr
adult
vasculit
syndrom
evid
efficaci
blockad
paediatr
vascul
current
remain
anecdotalalbeit
promisingand
import
addit
armamentarium
diseas
recalcitr
convent
therapi
number
group
recent
describ
method
detect
endotheli
cell
compon
blood
may
allow
assess
molecular
event
associ
vascular
injuri
two
potenti
inform
method
report
endotheli
microparticl
emp
circul
detach
matur
endotheli
cell
cec
emp
releas
cell
surfac
respons
varieti
stimuli
associ
endotheli
injuri
includ
vascul
atherosclerosi
acut
coronari
event
thrombot
thrombocytopen
purpura
previous
demonstr
possibl
monitor
endotheli
injuri
vascul
children
detect
circul
emp
express
eselectin
effect
provid
window
activ
endothelium
cec
necrot
highli
activ
endotheli
cell
detach
vessel
wall
recent
shown
use
clinic
marker
endotheli
injuri
vascul
adult
stroke
pulmonari
hypertens
woywodt
et
al
suggest
cec
correl
diseas
activ
adult
anca
vascul
thu
use
diagnost
also
monitor
diseas
activ
respons
therapi
preliminari
data
pb
et
al
unpublish
suggest
cec
also
elev
children
activ
primari
system
vascul
may
also
use
novel
clinic
tool
monitor
diseas
activ
respons
treatment
recent
emerg
concept
support
sever
anim
human
studi
bone
marrowderiv
endotheli
progenitor
cell
epc
involv
normal
physiolog
pathophysiolog
repair
mechan
exampl
myocardi
vascular
regener
follow
myocardi
infarct
posttranspl
arteriosclerosi
discoveri
epc
asahara
et
al
repres
major
advanc
alter
understand
endotheli
repair
process
neovascularis
focus
consider
research
interest
area
research
show
peripher
blood
mononuclear
cell
healthi
adult
acquir
endotheli
celllik
phenotyp
vitro
incorpor
regener
capillari
murin
hindlimb
ischaemia
model
find
subsequ
confirm
sever
group
number
function
circul
epc
influenc
cardiovascular
risk
endotheli
respons
insult
associ
endotheli
injuri
human
diseas
prediseas
state
studi
date
includ
convent
atherosclerot
risk
factor
connect
tissueinflammatori
diseas
includ
rheumatoid
arthriti
system
sclerosi
wegen
granulomatosi
kawasaki
diseas
although
data
relat
children
limit
latter
small
studi
epc
known
origin
bone
marrow
function
normal
via
home
adher
region
damag
epc
respons
treatment
vascul
children
yet
studi
area
ongo
activ
research
vascul
young
predispos
prematur
atherosclerosi
sever
key
aspect
longterm
outcom
vascul
young
remain
ongo
concern
current
best
studi
ks
importantli
controversi
continu
whether
ks
constitut
risk
factor
prematur
atherosclerosi
histolog
find
seen
ks
arteri
site
previou
aneurism
lesion
long
diseas
resolut
appear
indistinguish
atherosclerosi
dhillon
et
al
studi
vascular
respons
reactiv
hyperaemia
brachial
arteri
use
highresolut
ultrasound
flowmedi
dilat
endothelialdepend
respons
reduc
ks
patient
compar
control
subject
mani
year
ill
even
patient
without
detect
earli
coronari
arteri
involv
longterm
case
control
studi
albisetti
et
al
show
ks
patient
like
impair
fibrinolyt
system
anoth
marker
endotheli
dysfunct
unrel
degre
coronari
arteri
involv
pilla
et
al
demonstr
reduc
arteri
distens
independ
risk
factor
cardiovascular
morbid
mortal
adult
assess
use
ultrasound
puls
wave
veloc
brachioradi
arteri
segment
children
kd
median
year
previous
find
recent
confirm
cheung
et
al
also
document
children
pan
contrast
anoth
recent
crosssect
studi
mccrindl
fail
demonstr
differ
brachial
arteri
reactiv
carotid
intimamedia
thick
follow
ks
although
degre
impair
blood
pressur
control
document
ambulatori
blood
pressur
monitor
kd
case
perhap
import
studi
novel
surrog
marker
vascular
injuri
longterm
epidemiolog
data
japan
fifth
look
longterm
outcom
cohort
patient
kd
enrol
mortal
rate
patient
without
cardiac
sequela
acut
phase
diseas
femal
patient
sequela
differ
normal
popul
mortal
rate
male
cardiac
sequela
howev
higher
normal
popul
thu
longterm
outlook
patient
coronari
involv
due
ks
particularli
male
must
remain
guard
present
time
excit
time
vascul
research
understand
pathogenesi
advanc
approach
novel
therapeut
approach
includ
increas
use
biolog
although
formal
clinic
trial
involv
children
still
lack
area
signific
challeng
loom
includ
establish
intern
research
network
databas
obtain
adequ
patient
number
therebi
enabl
power
studi
valid
classif
criteria
suitabl
paediatr
vasculitid
develop
tool
allow
reliabl
noninvas
monitor
diseas
activ
develop
robust
core
outcom
variabl
use
assess
outcom
clinic
trial
lastli
remain
question
regard
longer
term
cardiovascular
morbid
children
surviv
vascul
ultim
must
anticip
advanc
understand
environment
trigger
host
respons
shape
futur
novel
therapeut
approach
psv
young
